Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Price used: about $61.65, the last trade I could confirm (October 22, 2026, down roughly 5% on the day after the earnings release; Benzinga). Aggregators disagreed with each other and I could not confirm an official close, so treat this as approximate. The stock traded around $70–71 in July and August. Each $1 of price moves the multiples below by about 1.6%. Citizens is a competent, improving super-regional bank with a respectable franchise. It is not a wonderful business. Banks sit near the bottom of our list of things to own. The product is a commodity (money), the balance sheet is levered about 9x tangible assets to equity, and the owner's real return depends on credit losses, the yield curve and regulators, none of which management controls. The quarter was good: EPS was $1.41, up 34% from a year ago. ROTCE reached 15.1% and the efficiency ratio fell to 60.0%.
Recent filings analysed: 8-K (2026-10-30), 10-Q (2026-10-28), 8-K (2026-10-08), 10-Q (2026-08-03).
Stock screener · Superinvestor 13F holdings · Analyst sentiment